. DNA hypomethylation correlates with genomic damage in gastrointestinal cancer Distribution of the hypomethylation alterations detected by MS-AFLP in gastric (left) and colon (right) cancers. Only the loci that exhibited alterations in 4 or more tumors have been considered. Tumors have been ordered from top to bottom according to their genetic damage fraction (GDF) estimated by AP-PCR. There is a positive correlation (P<0.0001) between the level of hypomethylation and the genetic damage in both gastric and colon cancers.
. DNA hypomethylation correlates with genomic damage in gastrointestinal cancer Distribution of the hypomethylation alterations detected by MS-AFLP in gastric (left) and colon (right) cancers. Only the loci that exhibited alterations in 4 or more tumors have been considered. Tumors have been ordered from top to bottom according to their genetic damage fraction (GDF) estimated by AP-PCR. There is a positive correlation (P<0.0001) between the level of hypomethylation and the genetic damage in both gastric and colon cancers. Unsupervised clustering analysis of the colon tumor series according to their level of hypomethylation (left) or hypermethylation (right) alterations. Only tumors exhibiting at least three altered bands in the MS-AFLP analysis where considered for the clustering. The clustering was performed using the SOTArray server and the Tree viewer from the bioinformatics unit of the CNIO, publicly available at http://gepas.bioinfo.cnio.es/tools.html.
Figure S4. MS-AFLP provides an estimation of the overall hypomethylation alterations in colon cancer
The frequency of hypomethylated bands in MS-AFLP correlates with the levels of hypomethylation at genome-wide CpG sites by M.SssI / dam methylase assay. (a lower ratio mCpG%, indicates stronger hypomethylation). CpG sites were methylated by M.SssI methylase and GATC sites by dam methylase using the same test conditions. Labeled methyl donor was S-adenosyl-[methy-
3 H]methionine. By the M.SssI methylase the labeled methyl-3 H was incorporated in previously unmethylated CpG sites among the whole genome. GATC sites are never methylated in mammalian DNA, therefore it was used for internal quantification of DNA. With the combination of both assays the percentage of methylated CpG was estimated from the ratio between M.SssI and dam methylase 3 H incorporation. There was significant correlation between the frequency of hypomethylated bands in the MS-AFLP and the severity of hypomethylation of CpG sites (r 2 =0.26, p<0.001, Figure 4 top left). The association was independent of MSI status and anatomical localization (Figure 4 , top right, and bottom). The relative high noise and low correlation value may be explained by the under-representation of NotI sites in some repetitive sequences. None of the bands hit an ALU or a LINE repeat. Figure S5 . Genome localization of some altered CpG loci in repetitive sequences detected by MS-AFLP Location and number of hits in the genome of MER96 (top), HERV9 (middle) and MER92C (bottom), three of the repetitive elements found in MSAFLP bands. Red marks represent individual hits and the total number of hits per chromosome is indicated, in red, below each chromosome. Other MSAFLP bands contained different repetitive elements that are too abundant to map, i.e. 3 bands with LTR12C (3,469 hits), 1 band with MLT1C (16,488 hits) and 7 bands with MIR sequences (more than 500,000 hits). The scan of a repetitive element consensus sequence database revealed the existence of only 2 consensus sequences with NotI sites: MER57I and HERVK11I, providing a plausible explanation for the relatively low frequency of repetitive elements in the MSAFLP studies. In general, the NotI site in the repetitive element-containing MSAFLP bands was not inside but adjacent to the repetitive element. Although some bands reflected the methylation status of repetitive sequences in the genome (i.e. band 5 of Figures 1 and 2) 
